The Enterprise Value as of December 2025 (TTM) for Minerva Neurosciences, Inc. (NERV) is 70.91M

According to Minerva Neurosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 70.91M. This represents a change of 27.49% compared to the average of 55.62M of the last 4 quarters.

Minerva Neurosciences, Inc. (NERV) Historical Enterprise Value (quarterly & annually)

How has NERV Enterprise Value performed in the past?

The mean historical Enterprise Value of Minerva Neurosciences, Inc. over the last ten years is 133.51M. The current 70.91M Enterprise Value has changed 5.21% with respect to the historical average. Over the past ten years (40 quarters), NERV's Enterprise Value was at its highest in in the September 2016 quarter at 409.26M. The Enterprise Value was at its lowest in in the December 2022 quarter at -27603006.00.

Minerva Neurosciences, Inc. (NERV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Minerva Neurosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Minerva Neurosciences, Inc. (NERV) Average Enterprise Value

How has NERV Enterprise Value performed in the past?

The current Enterprise Value of Minerva Neurosciences, Inc. (NERV) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Minerva Neurosciences, Inc. (NERV) Enterprise Value vs. Peers

How is NERV’s Enterprise Value compared to its peers?

Minerva Neurosciences, Inc.’s Enterprise Value is greater than Klotho Neurosciences, Inc. (18.48M), greater than Sonnet BioTherapeutics Holdings, Inc. (8.18M), greater than NeuroSense Therapeutics Ltd. (28.93M), greater than Exicure, Inc. (35.58M), greater than NeurAxis, Inc. (24.74M), greater than CollPlant Biotechnologies Ltd. (21.10M), greater than TAO Synergies Inc. (8.89M), greater than Rallybio Corporation (18.77M), greater than Cadrenal Therapeutics, Inc. Common Stock (19.18M), greater than Enlivex Therapeutics Ltd. (24.70M),

Build a custom stock screener for Minerva Neurosciences, Inc. (NERV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Minerva Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Minerva Neurosciences, Inc. (NERV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Minerva Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.